The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 21.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (4 analysts) rates it buy, with a mean price target of $56.
OR Royalties Inc.
OR · the NYSE · USD · Market cap $6.8B
OR Royalties Inc.
PASS · Titan Ethical · score 70.0At the last full screen
2026-09-11
Screened 2026-09-11 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
OR Royalties Inc. holds its Markup at $36.03. Consolidating, no directional conviction, held for 81 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 81 days |
| Price at the screen | $36.03 |
| Valuation | 24.02 trailing · 26.01 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.37 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 0.32% | Below 33% | Interest-bearing debt is just 0.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 10.40% | Below 33% | Cash held in interest-bearing accounts and securities is 10.4% of assets, under the one-third limit. | Pass |
| Receivables | 9.22% | Below 49% | Money owed to the company is 9.2% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.45% | Below 5% | Only 1.4% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. The price runs 23.4% above the base estimate.
Third-party analyst targets: 4 covering, consensus Hold. The average target sits +21% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsGold royalties look tempting but hide cycle traps
Picture a landlord who never swings a pickaxe yet takes a cut every time ore leaves the ground. OR Royalties has built exactly that model, posting 87 percent revenue growth and a 78 percent profit margin while delivering 19 percent return on equity. The business clears our ethical screen without issue, yet the shares sit slightly above our fair value with almost no margin of safety.
Forward earnings trade at 19.4 times, not the bargain multiple some expect in resources. Analyst targets sit far higher, yet those forecasts often assume gold prices stay elevated. In a cyclical sector, peak margins and growth rates can flatten quickly once metal prices turn.
The real risk is the classic value trap: earnings look robust today because commodity prices are strong, but multiples compress and volumes fall when the cycle rolls over. Currency moves and project delays add further volatility. Analysis, not advice.
| Forward P/E | 26.0xcheap for a company growing this fast |
| Trailing P/E | 24.0xa premium valuation |
| EPS, trailing | 1.50 |
| EPS, forward | 1.39 |
| Revenue growth | +62.0%growing very fast |
| Profit margin | 78.0%highly profitable on every dollar of sales |
| Return on equity | 20.4%an exceptional return on shareholder capital |
| FCF yield | -2.51% |
| Dividend yield | 77.00% |
| Debt to equity | 0.15minimal debt: a conservative balance sheet |
| Current ratio | 2.28comfortably covers its short-term bills |
| Beta | 1.37moves a little more than the market |
| 52-week range | 27.54 - 48.06 |
| Market cap | $6.8B |
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeOR trades on the NYSE (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (4 analysts) rates it buy, with a mean price target of $56.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (4 analysts) rates it buy, with a mean price target of $56.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 9 Sept2024 | Tracey Mann | Republican | sell | 1K–15K |
| 9 Sept2024 | Tracey Mann | Republican | sell | 1K–15K |
| 9 Sept2024 | Tracey Mann | Republican | sell | 1K–15K |
| 9 Sept2024 | Tracey Mann | Republican | sell | 1K–15K |
| 9 Sept2024 | Tracey Mann | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $39.80 | -20.5% | · | $795 | -20.5% |
| 2 months | $39.44 | -19.8% | · | $802 | -19.8% |
| 3 months | $41.98 | -24.6% | $0.06 | $755 | -24.5% |
| 6 months | $35.85 | -11.7% | $0.06 | $884 | -11.6% |
| 1 year | $25.58 | +23.7% | $0.11 | $1,241 | +24.1% |
| 2 years | $16.82 | +88.1% | $0.30 | $1,899 | +89.9% |
| 3 years | $15.64 | +102.4% | $0.47 | $2,054 | +105.4% |
| 5 years | $13.80 | +129.3% | $0.81 | $2,352 | +135.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever OR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.